trial

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

NCTId NCT02102113
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Early Phase 1 · Active Not Recruiting
Enrollment 21 (estimated)
Sponsored by Yale University
Primary completion 2026-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Early Phase 1
Status
Active Not Recruiting
Enrollment
21 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2014-01
Primary completion
2026-06
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
Very Low Dose THCLow Dose THC

Sponsors

Yale UniversityLead Sponsor

Investigators

1
Mohini Ranganathan, MBBSPrincipal Investigator

Sites

1 total
West Haven, United States

Facts & assertions

4 sourced
Enrollment
21
Phase
EARLY_PHASE1
Primary Completion Date
2026-06
Status
ACTIVE_NOT_RECRUITING
relationships
The graph out of here
drug
Very Low Dose THC
drug
Low Dose THC
drug
lead_sponsor
Yale University
company
indication
Psychosis
indication
Marijuana
indication
Marijuana Abuse
indication
investigator
Mohini Ranganathan, MBBS
person